Description
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
Product Unit Size | Cost | Quantity | Stock |
---|
3,4-Difluorobenzocurcumin is a derivative of curcumin that, like its parent compound, may display antioxidative, anti-inflammatory, chemopreventive, and antibacterial activities.
Cas No. | 1170354-22-9 |
---|---|
Purity | ≥95% |
Formula | C28H22F2O6 |
Formula Wt. | 492.47 |
Chemical Name | (1E,6E)-1,7-bis-(4-hydroxy-3-methosyphenyl) hepta-1,6-diene [4(3,4-difluorobenzaldehyde)]-3,5-dione |
IUPAC Name | (1E,6E)-4-[(3,4-difluorophenyl)methylidene]-1,7-bis(4-hydroxy-3-methoxyphenyl)hepta-1,6-diene-3,5-dione |
Synonym | Difluorobenzocurcumin, 3,4-Difluorobenzocurcumin, CDF |
Melting Point | 214-217°C |
Solubility | DMSO, 110mg/mL |
Appearance | Bright Yellow Powder |
Store Temp | Ambient |
---|---|
Ship Temp | Ambient |
MSDS | |
---|---|
Info Sheet | |
Brochures | |
Okuda KS, Ng MF, Ruslan NF, et al. 3,4-Difluorobenzocurcumin inhibits Vegfc-Vegfr3-Erk signalling to block developmental lymphangiogenesis in zebrafish. Pharmaceuticals (Basel). 2021 Jun 26;14(7):614. PMID: 34206901.
Broad-spectrum antibiotic
Docetaxel impurity
Peptide, cleavage product of proenkephalin; κO...
FIASMA; α1- and β1/2-adrenergic antagonist.
NMDA potentiator, GABA-A antagonist.
SIRT inhibitor.
Water-soluble coenzyme, vitamin (B7) found in v...
Endogenous tachykinin peptide, involved in infl...
Impurity of omeprazole
Thiazide diuretic; NCCT inhibitor, carbonic anh...
5-HT1A agonist, 5-HT2A antagonist.
R,R enantiomer of formoterol; β2-adrenergic an...
Pyramido-pyrrolo-quinoxalinedione; CFTR blocker...
PI3K inhibitor.
Triterpene saponin found in species of Panax; A...
Imidazole; 14-α demethylase inhibitor, potenti...
Caffeic acid derivative.
Synthetic steroid; glucocorticoid agonist.
GSK-3 inhibitor.
Allosteric inhibitor